Skip to content

Clinical trial of Saroglitazar Magnesium by Zydus Therapeutics shows favorable main results in stage 2(b)/3, for patients afflicted with primary biliary cholangitis (PBC).

Treatment with Saroglitazar 1mg demonstrated a marked advantage over placebo, showcasing a 48.5% higher chance of biochemical response in trials.

Clinical trial of Saroglitazar Magnesium by Zydus Therapeutics shows promising outcomes in patients...
Clinical trial of Saroglitazar Magnesium by Zydus Therapeutics shows promising outcomes in patients with primary biliary cholangitis, based on the results from EPICS-III Phase 2(b)/3 study.

Clinical trial of Saroglitazar Magnesium by Zydus Therapeutics shows favorable main results in stage 2(b)/3, for patients afflicted with primary biliary cholangitis (PBC).

In a significant move, Canon Medical Systems India has signed a Memorandum of Understanding (MoU) with Rajiv Gandhi Cancer Institute. This collaboration aims to bolster the fight against cancer and potentially pave the way for improved diagnostic services.

Meanwhile, the National Health Authority (NHA) recently organised a consultation meeting as part of ABDM 2.0 (Ayushman Bharat Digital Mission 2.0). The meeting, held at the International Institute of Information Technology, Hyderabad (IIITH), focused on the southern region.

The funding for India's pharmaceutical and healthcare sectors took a steep dive in August 2025, with investments dropping by 82% to $47 million. This decline could have implications for the future growth of the industry, with experts suggesting that the future of healthcare growth lies primarily in Tier 2 and Tier 3 cities.

In an attempt to support children with learning difficulties, the Madras Dyslexia Association has developed a 'Count on Me' toolkit. This initiative aims to provide resources and strategies to help children with dyslexia overcome their challenges and thrive in their educational journey.

Unfortunately, the specific organization associated with the ABDM 2.0 consultation committee meeting in the South could not be identified from the provided search results. None of the sources consulted mentioned the identity of this specific organization.

As the healthcare landscape continues to evolve, it's clear that collaboration, innovation, and a focus on underserved areas will be key to driving progress and improving outcomes for all.

Read also: